Güzel Y - Search Results

1

⁶⁸Ga-FAPI-04 PET/CT, a new step in breast cancer imaging: a comparative pilot study with the ¹⁸F-FDG PET/CT.

Kömek H, Can C, Güzel Y, Oruç Z, Gündoğan C, Yildirim ÖA, Kaplan İ, Erdur E, Yıldırım MS, Çakabay B. Kömek H, et al. Among authors: guzel y. Ann Nucl Med. 2021 Jun;35(6):744-752. doi: 10.1007/s12149-021-01616-5. Epub 2021 May 2. Ann Nucl Med. 2021. PMID: 33934311

2

Evaluation of dual time-point fluorodeoxyglucose PET/computed tomography imaging in gastric cancer.

Tasdemir B, Güzel Y, Komek H, Can C. Tasdemir B, et al. Among authors: guzel y. Nucl Med Commun. 2020 Dec;41(12):1322-1327. doi: 10.1097/MNM.0000000000001290. Nucl Med Commun. 2020. PMID: 32956249

3

False-Positive 68Ga-Fibroblast Activation Protein-Specific Inhibitor Uptake of Benign Lymphoid Tissue in a Patient With Breast Cancer.

Gündoğan C, Güzel Y, Can C, Alabalik U, Kömek H. Gündoğan C, et al. Among authors: guzel y. Clin Nucl Med. 2021 Aug 1;46(8):e433-e435. doi: 10.1097/RLU.0000000000003594. Clin Nucl Med. 2021. PMID: 33782295

4

68Ga-FAPI Uptake of Thyroiditis in a Patient With Breast Cancer.

Can C, Gündoğan C, Güzel Y, Kaplan İ, Kömek H. Can C, et al. Among authors: guzel y. Clin Nucl Med. 2021 Aug 1;46(8):683-685. doi: 10.1097/RLU.0000000000003637. Clin Nucl Med. 2021. PMID: 33826569

5

Role of ⁶⁸Ga-PSMA PET/CT parameters in treatment evaluation and survival prediction in prostate cancer patients compared with biochemical response assessment.

Can C, Gündoğan C, Yildirim OA, Poyraz K, Güzel Y, Kömek H. Can C, et al. Among authors: guzel y. Hell J Nucl Med. 2021 Jan-Apr;24(1):25-35. doi: 10.1967/s002449912303. Epub 2021 Apr 20. Hell J Nucl Med. 2021. PMID: 33866336 Free article.

6

Efficacy of 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting response to second-generation androgen receptor axis-targeted therapy, and the prognosis in metastatic hormone-refractory prostate cancer patients.

Oruç Z, Güzel Y, Ebinç S, Kömek H, Küçüköner M, Kaplan MA, Oruç İ, Urakçi Z, Işikdoğan A. Oruç Z, et al. Among authors: guzel y. Nucl Med Commun. 2021 Dec 1;42(12):1336-1346. doi: 10.1097/MNM.0000000000001464. Nucl Med Commun. 2021. PMID: 34366407

7

68Ga-FAPI-04 PET/CT Versus 18F-FDG PET/CT in Malignant Peritoneal Mesothelioma.

Gündoğan C, Güzel Y, Kömek H, Etem H, Kaplan İ. Gündoğan C, et al. Among authors: guzel y. Clin Nucl Med. 2022 Feb 1;47(2):e113-e115. doi: 10.1097/RLU.0000000000003858. Clin Nucl Med. 2022. PMID: 34392282

8

Nivolumab-Related Dry Mouth and Dry Eye: Cross-Sectional Study.

Yildirim OA, Poyraz K, Erdur E, Can C, Gundogan C, Guzel Y, Etem H, Kömek H. Yildirim OA, et al. Among authors: guzel y. Cancer Invest. 2021 Nov;39(10):797-807. doi: 10.1080/07357907.2021.1971241. Epub 2021 Sep 22. Cancer Invest. 2021. PMID: 34415812

9

Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.

Gündoğan C, Kömek H, Can C, Yildirim ÖA, Kaplan İ, Erdur E, Poyraz K, Güzel Y, Oruç Z, Çakabay B. Gündoğan C, et al. Among authors: guzel y. Nucl Med Commun. 2022 Jan 1;43(1):64-72. doi: 10.1097/MNM.0000000000001489. Nucl Med Commun. 2022. PMID: 34661379

10

18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT Findings of Abdominal Leiomyosarcoma.

Güzel Y, Can C, Söğütçü N, Gündeş E, Gündoğan C. Güzel Y, et al. Clin Nucl Med. 2021 Dec 1;46(12):e594-e597. doi: 10.1097/RLU.0000000000003673. Clin Nucl Med. 2021. PMID: 34735413

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters